Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2017-03-18 2017-03-17
Drug Identification Number 02279401 02279401
Brand name REVATIO REVATIO
Common or Proper name REVATIO REVATIO
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SILDENAFIL SILDENAFIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6x15 6x15
ATC code C02 C02
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-19 2017-01-19
Estimated end date 2017-03-15 2017-03-15
Actual end date 2017-03-17 2017-03-17
Shortage status Resolved Actual shortage
Company comments Resolved March 17, 2017 / Résolu 17 mars 2017 Resolved March 17, 2017 / Résolu 17 mars 2017
Health Canada comments